AD Real-World Evidence and Clinical Data Companies

AD Real World Evidence Companies

This page provides a comprehensive overview of companies providing real-world evidence (RWE) platforms, clinical data analytics, and real-world data (RWD) services for Alzheimer's disease (AD) research and drug development. These companies play a critical role in generating evidence from real-world clinical settings to support regulatory decisions, post-marketing surveillance, and clinical outcomes research[@cummings2024].

Overview

Real-world evidence companies support the AD research ecosystem through:

• Electronic Health Record (EHR) Data Aggregation: Pooling patient data from healthcare systems
• Claims Data Analytics: Analyzing insurance and billing data for treatment patterns
• Patient Registries: Longitudinal observational studies tracking patient outcomes
• Post-Marketing Surveillance: Monitoring drug safety and effectiveness in real-world populations
• Comparative Effectiveness Research: Comparing outcomes across treatments and care settings
• Clinical Trial Optimization: Patient recruitment, site selection, protocol feasibility

Major RWE and Data Analytics Companies

IQVIA

[IQVIA](/companies/iqvia) (formerly IMS Health) is a leading global provider of real-world healthcare data and analytics. The company offers one of the largest repositories of anonymized patient data globally.

AD Real World Evidence Companies

This page provides a comprehensive overview of companies providing real-world evidence (RWE) platforms, clinical data analytics, and real-world data (RWD) services for Alzheimer's disease (AD) research and drug development. These companies play a critical role in generating evidence from real-world clinical settings to support regulatory decisions, post-marketing surveillance, and clinical outcomes research[@cummings2024].

Overview

Real-world evidence companies support the AD research ecosystem through:

• Electronic Health Record (EHR) Data Aggregation: Pooling patient data from healthcare systems
• Claims Data Analytics: Analyzing insurance and billing data for treatment patterns
• Patient Registries: Longitudinal observational studies tracking patient outcomes
• Post-Marketing Surveillance: Monitoring drug safety and effectiveness in real-world populations
• Comparative Effectiveness Research: Comparing outcomes across treatments and care settings
• Clinical Trial Optimization: Patient recruitment, site selection, protocol feasibility

Major RWE and Data Analytics Companies

IQVIA

[IQVIA](/companies/iqvia) (formerly IMS Health) is a leading global provider of real-world healthcare data and analytics. The company offers one of the largest repositories of anonymized patient data globally.

| Service | Description |
|---------|-------------|
| Real-World Data | EHR data from 800M+ patient records |
| Analytics Platform | Cloud-based analytics for RWE generation |
| AD Specific | Dementia and Alzheimer's disease cohorts |

IQVIA's AD data capabilities include:

• Longitudinal patient journey analysis
• Treatment pattern studies
• Healthcare resource utilization
• Outcomes research support
• Cognitive decline progression modeling
• Biomarker validation datasets[@iqvia2024]

Optum

[Optum](/companies/optum) is a major healthcare technology company part of UnitedHealth Group, providing advanced data analytics and RWE solutions.

| Capability | Application in AD |
|------------|------------------|
| Claims Data | Medicare Advantage, commercial claims |
| EHR Data | 100M+ de-identified patient records |
| Analytics | Machine learning for patient stratification |
| Registries | Neurodegenerative disease registries |

Optum's AD research capabilities include:

• Population health management
• Risk adjustment modeling
• Quality measures tracking (MMSE, MoCA scores)
• Clinical trial feasibility
• Cognitive decline tracking from MCI to AD[@optum2024]

Syneos Health

[Syneos Health](/companies/syneos-health) provides end-to-end clinical development solutions including real-world evidence generation.

| Service | Description |
|---------|-------------|
| RWE Design | Pragmatic trials and observational studies |
| Data Collection | Prospective and retrospective data |
| Regulatory Support | FDA, EMA, PMDA submissions |
| HEOR | Health economics and outcomes research |

Syneos supports AD drug development through:

• Post-authorization safety studies
• Patient-reported outcomes
• Natural history studies
• Burden of illness research
• Comparative effectiveness studies[@syneos2024]

Specialized Healthcare Data Companies

MEDINFORM

[MEDINFORM](/companies/medinform) specializes in clinical data management and analytics for pharmaceutical research.

| Focus Area | Capabilities |
|------------|-------------|
| Clinical Data | CDISC standards, data management |
| Analytics | Statistical analysis, reporting |
| AD Studies | Cognitive assessment databases, biomarker data |

MEDINFORM provides:

• Clinical data warehousing
• Multi-source data integration
• Medical coding (ICD-10, SNOMED, MedDRA)
• Regulatory submissions (IND, NDA, BLA)[@medinform2024]

Cerebras Systems

[Cerebras Systems](/companies/cerebras) provides AI computing infrastructure that enables advanced analytics on healthcare data.

| Technology | Application |
|------------|-------------|
| WSE-3 | Large-scale neural network training |
| Memory | 44GB on-chip SRAM for fast processing |
| Parallel Compute | Massive parallelism for big data |

For AD research, Cerebras enables:

• Machine learning for early detection
• Protein folding simulations for amyloid research
• Drug candidate screening
• Real-time neural signal processing[@cerebras2024]

Health Catalyst

[Health Catalyst](/companies/health-catalyst) offers AI-powered analytics and population health management for dementia care:

• AI-powered analytics: Population health management
• Outcomes measurement: Standardized cognitive and functional outcomes
• Data warehousing: Integrated clinical and claims data platforms
• Quality metrics: HEDIS measures for dementia care[@healthcat]

Cegedim

[Cegedim](/companies/cegedim) provides European healthcare data:

• European RWE: Multi-country EHR data from EU practices
• AD Registry Data: Longitudinal patient registries
• Real-World Analytics: Post-authorization safety studies
• Cross-border Coverage: Pan-European data for studies[@cegedim]

TriNetX

[TriNetX](/companies/trinetx) offers a global research network:

• Global Network: 200+ healthcare organizations, 500M+ patients
• AD Cohort Discovery: Protocol feasibility and site selection
• Counterfactual Analysis: Synthetic control arm generation
• Virtual Trials: Hybrid and decentralized trial support[@trinetx]

Additional RWE Providers

Claims and EHR Data

| Company | Data Type | AD Focus |
|---------|-----------|----------|
| Flatiron Health | Oncology/EHR | Expanding to CNS |
| Cerner | EHR | Oracle Health integration |
| Epic | EHR | Cognitive assessment integration |
| Allscripts | EHR | Specialty data |

Analytics and Technology

| Company | Capability |
|---------|------------|
| SAS Institute | Analytics platform |
| Tableau | Data visualization |
| Snowflake | Healthcare data cloud |
| Databricks | Big data analytics |

Data Sources and Registries

AD-Specific Data Sources

| Source | Type | Description |
|--------|------|-------------|
| Alzheimer's Disease Neuroimaging Initiative (ADNI) | Cohort Study | Longitudinal biomarker and clinical data |
| National Alzheimer's Coordinating Center (NACC) | Registry | Clinical and neuropathological data |
| Framingham Heart Study | Cohort | Cognitive decline tracking |
| UK Biobank | Biobank | Genetic and health data linkage |

Claims and EHR Databases

| Database | Provider | Key Features |
|----------|----------|---------------|
| MarketScan | IQVIA | Commercial claims data |
| National Drug Code (NDC) | FDA | Pharmaceutical utilization |
| SEER-Medicare | NCI | Cancer outcomes linked to AD |
| Optum Labs Data Warehouse | Optum | Integrated EHR and claims |

Regulatory Context

Real-world evidence in AD is increasingly important for:

The 21st Century Cures Act and FDA RWE framework have accelerated adoption of real-world data in neurodegenerative disease research.

Applications in AD Research

Clinical Trial Optimization

• Patient recruitment: Matching criteria to RWD cohorts
• Site selection: Identifying high-enrolling sites via historical data
• Endpoint validation: Correlating clinical endpoints with real-world measures

Disease Progression Modeling

• Natural history studies: Understanding AD progression rates
• Biomarker validation: RWE for biomarker-performance correlation
• Subgroup identification: Responsive patient populations

Health Economics

• Burden of disease: Cost-of-illness studies
• Care pathway analysis: Healthcare utilization patterns
• Value assessment: Cost-effectiveness of emerging therapies

See Also

• [AD Diagnostic and Imaging Companies](/companies/ad-diagnostic-imaging-companies)
• [AD Pipeline Companies](/companies/ad-pipeline-companies)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Clinical Trials](/clinical-trials)
• [Biomarkers](/biomarkers)

External Links

• [FDA Real-World Evidence](https://www.fda.gov/science-research/science-and-research-topics/real-world-evidence)
• [C-Path](https://c-path.org/) - Critical Path for Alzheimer's
• [ICARE](https://www.alz.org/research/icare) - Alzheimer's Association ICARE

References